(Information sent by the signatory company)
The new international agreement builds on work already done to improve cancer care and outcomes worldwide by adapting and applying evidence-based guidelines for Poland and other countries.
PLYMOUTH MEETING, Pa., Feb. 27, 2023 /PRNewswire/ -- The National Comprehensive Cancer Network® ( NCCN®), a nonprofit alliance of America's leading cancer centers, today announced a new collaboration with the Polish Institute of Hematology and Transfusion Medicine (IHIT) and the Alliance For Innovation-Polish-American Foundation (AFI). The three organizations have signed an agreement that allows doctors to share their knowledge and experience internationally in order to improve the quality of care and outcomes for patients with haematological malignancies in Poland and around the world.
"This new agreement underscores our commitment to further advance our collaboration with Polish colleagues to standardize and improve the way cancers are treated," said Robert W. Carlson, MD, NCCN CEO. "The Polish Institute of Hematology and Transfusion Medicine is the leading hematology research and medical hospital in Poland, serving as the national clinical and diagnostic reference center. Together, we can ensure that more people with blood cancers receive proper treatment to your region based on the latest evidence and expert consensus.
This new agreement builds on a multi-year collaboration between the NCCN, the Marie Curie-Sklodowska National Cancer Research Institute, the Ministry of Health of the Republic of Poland and AFI to improve country-specific guidelines for diagnostic and therapeutic procedures. of solid tumors in Poland, based on the NCCN Clinical Practice Guidelines in Oncology (NCCN® Guidelines), as required by the Polish National Cancer Strategy. The NCCN® Guidelines are the recognized standard for clinical direction and policy in cancer treatment and the most comprehensive and frequently updated clinical practice guidelines available in any area of medicine. They have been translated, adapted and harmonized in collaboration with local and regional experts, advocates and policy makers from Sub-Saharan Africa, the Middle East and North Africa (MENA), the Caribbean, Asia, South America and Europe, in order to make them more relevant and accessible to patients and healthcare professionals around the world. Initial work with Poland started in 2021; To date, the groups have co-developed Polish adaptations of the NCCN guidelines for:
"Our main goal is to improve the quality of care and outcomes for hematology patients in Poland," said Professor Ewa Lech-Marańda, Director of IHIT. "Cooperation between our institutions will include the development of tailored clinical guidelines based on NCCN knowledge, experience and expertise, as well as long-standing procedures for continuous updates."
"The signing of an agreement between such important institutions for cancer control is of great importance for patients and the cancer community, as well as for the future development of Polish-American cooperation," said Marcin Hańczaruk, AFI Co-President.
NCCN's resources for patients and cancer care providers are widely accessed and used free of charge around the world. Nearly half of the 1.7 million registered users who view the NCCN guidelines on NCCN.org or through the Virtual Library of NCCN Guidelines® app are located outside of the United States. Learn more about NCCN's collaborative work to define and promote high-quality, high-value, patient-centered cancer care globally at NCCN.org/global.
About the National Comprehensive Cancer Network The National Comprehensive Cancer Network® (NCCN®) is a nonprofit alliance of leading cancer centers dedicated to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so that all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN® Guidelines) provide transparent, evidence-based, and expert-consensus recommendations for cancer treatment, prevention, and support services; They are the recognized standard for clinical direction and policy in the management of cancer and the most comprehensive and frequently updated clinical practice guidelines available in any area of medicine. The NCCN Patient Guidelines® provide expert information on cancer treatment to inform and empower patients and caregivers, supported by the NCCN Foundation®. NCCN also promotes continuing education, global initiatives, policy, and collaboration in oncology research and publication. Visit NCCN.org for more information.
Media Contact: Rachel Darwin 267-622-6624darwin@nccn.org
Logo - https://mma.prnewswire.com/media/441768/...
View original content: https://www.prnewswire.com/news-releases/la-national-comprehensive-cancer-network-anuncia-su-colaboracion-con-expertos-en-cancer-de-sangre-de-polonia-301754415.html
